Citryll

Citryll is a Targeting Neutrophil Extracellular Traps. Citryll is backed by investors that include BOM Brabant Ventures, BrightGene, Curie Capital, and ModiQuest B.V. and is headquartered in Netherlands.
The Pulse of New York Tech
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.